LifeMine Therapeutics Company
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Total Funding:
295000000.0
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
Late Stage Venture
Employee Number:
51-100
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Technology:
['BioTech & HealthTech']
Last Funding Date:
2022-03-23
Investors Number:
14.0
Founded Date:
2016-01-01
Industry:
Medical BioTech